Intellectual deterioration is a hallmark of Huntington's disease that in some patients predates the development of chorea.' 2 While dementia in advanced cases is attributable to widespread degenerative changes in the brain, especially the frontal cortex,' 3 4 the pathophysiology of intellectual changes seen in the early stages of the illness is unclear. Neuropathological and neurochemical changes in the cortex of early cases are usually mild and occasionally absent. 3 56 Evidence of frontal atrophy on CT scan does not reliably predict degree of dementia.710 Moreover, and perhaps most surprising of all, studies of brain glucose metabolism using positron emission tomography (PET) have found that frontal cortex metabolic rates tend to be normal in other than advanced cases.'0 -13 In spite of this lack of direct neuropathological data, the concept of the dementia of Huntington's disease being a frontal lobe type dementia has a long history and is supported by considerable indirect evidence. Two of Huntington's original case descriptions include references to social inappropriateness and poor judgement suggestive of prefrontal dysfunction. '4 More recently, studies of the behavioural changes and the pattern of deficits on formal neuropsychological testing seen in this illness have stressed the similarity of the results to findings in patients with unequivocal frontal lobe disease.' 8 15-19 An alternative and increasingly popular view is that the dementia of Huntington's disease is a so-called "subcortical dementia" linked directly to pathology of the basal ganglia. [20] [21] [22] [23] [24] This view implies that certain intellectual functions are processed in the basal ganglia or at least that they are fundamentally dependent on the integrity of the basal ganglia. The "subcortical" dementia concept is controversial and primarily theoretical.232526 There are little direct experimental data to support it. While some studies have shown a relationship between caudate atrophy on CT and intellectual function, 8 others have not.7 9-11 Likewise, despite consistent PET findings of reduced caudate glucose metabolism,'0-13 the magnitude of the reduction has not consistently predicted the degree of dementia.'0
In this report we describe a potentially more informative approach to exploring the pathophysiology of the dementia of Huntington's disease. It involves the simultaneous assessment of prefrontal cortical blood flow and prefrontal cognitive function. Information about how these parameters are related in Huntington's disease may help clarify the pathophysiology of the cognitive impairment. The findings suggest that prefrontal type cognitive deficits are not the result of Prefrontal cortical bloodflow and cognitive function in intrinsic prefrontal disease or dystunction but reflect the impact of caudate pathology on normal prefrontal physiology.
Methods
Subjects Fourteen patients with adult onset Huntington's disease (seven men, seven women) ages 25 to 61 (mean 41 9) participated in the study. Diagnosis was made on the basis of a positive family history, the presence of chorea, deterioration in cognitive function, and in most cases (see below) presence of caudate atrophy on CT scan. Complete neurological examinations, automated blood chemistry analyses, thyroid function tests, and peripheral blood smears were not suggestive of other aetiologies of the abnormal movements. The onset of chorea as determined by historical accounts ranged from I to 19 years (mean 6-4), and the diagnosis had been made from I month to 10 years (mean 3 7) before the study. According to the staging criteria of Shoulson and Fahn,27 three patients were stage I, seven were stage II, three were stage III, and one was stage IV. Two patients required continuous institutional care and were taking haloperidol 5 mg per day. The rest of the group were outpatients and were medication-free.
Fourteen 19 The other task was a simple automated number matching (NM) procedure performed on the identical apparatus as in the WCS. This task served two purposes: it was a nonprefrontally specific and simple mental activity that patients with Huntington's disease could complete without obvious difficulty; and it served as an active baseline state against which rCBF during the WCS could be compared. In keeping with this latter purpose, the NM was conceived as an individualised control for aspects of the WCS-rCBF experience other than DLPFC-specific cognitive function. These included the minimal finger movement involved in pressing a switch to make a response, the eye scanning and visual stimulation involved, and the emotional and psychological experience of taking a test during which rCBF is measured. In theory, these factors remained relatively constant from one task to another. We have previously found that by examining differences in rCBF between the NM and the WCS, those aspects of the WCS rCBF that are specific to the WCS may be better isolated. 30 Coniputed tonmographj High resolution CT scans that had been performed within 6 months of the rCBF procedure were available for 10 patients. Caudate atrophy was assessed using the frontal horn-caudate ratio (FCR),940 a measure that varies inversely with degree of caudate atrophy (that is, lower ratios correspond to more atrophy). One patient had a frontal-caudate ratio of 2 1. the only value that fell within the normal range.9 40 The other patients had values ranging from 1-2 to 1-6.
Peripheral phlvsiologictl (dta( Several peripheral physiological measures were continuously monitored on a polygraph during each rCBF procedure, including pulse ratte, respiratory rate, skin conductance (GSR), and end expiratory partial pressure of carbon dioxide (pCO2). The dutonomic measures were used to evaluate a possible effect of nonspecific arousal and anxiety on rCBF data. Polygraphic recordings were scored as previously described.3" The interpretation of absolute rCBF data is complicated by the effect of blood pCO2. Since rCBF varies directly with pCO2,41 -it is possible that group rCBF differences could be an artifact of ventilatory differences. One approach to this problem has been to apply a correction factor29 44 (fig la) . Regional analysis showed no significant group differences by MANOVA and no individual region was significantly different by univariate ANOVA, though Huntington's disease patients had slightly lower mean rCBF in each region. There was, however, a significant difference in respiratory rate and in mean end-expiratory pCO2 (patients, 37-1 + 1 4mmHg; controls, 46 2 + 0-9, p < 0-0001, t test). pCO2 correction resulted in elevating rCBF in the Huntington's disease patients to values slightly above those of the controls, and MANOVA analysis revealed a significant overall group effect (Wilks' Lambda = 0 61, F(5,22) = 2 77, p < 0-05), but no significant individual region differences (fig 2a) . Relative distribution analysis, as shown in fig 3a, revealed a trend towards an overall group effect (Wilks' Lambda = 0-63, F (5, 22) = 2 55, p < 0 06), with Huntington's disease patients having greater relative flows to prefrontal and temporal regions. NM Condition During the NM condition, the rCBF pattern was again similar in both groups (fig 1 b) . There was no overall group effect or individual region differences in the region analysis. Despite significant differences in pCO2 (patients, 36-2 + 1 5; controls, 42 5 + 0 9, p < 0 01), pCO2 correction did not change the results of the analyses (fig2b). Relative distribution analysis also showed no group differences (fig 3b) . WCS Condition During the WCS test, both groups again demonstrated similar rCBF patterns (fig lc, d ).
There were no group differences by any of the analyses (figs 2c, 3c).
As The results of this study confirm and extend earlier reports of quantitatively normal cortical metabolism in patients with mild to moderately advanced Huntington's disease. Consistent with most studies of glucose metabolism using PET,10 -13 we found that cortical rCBF during the so-called "resting state" was not diminished in patients with this illness. In contrast to previous reports, we also studied Huntington's disease patients while they were engaged in a reasoning task and found that even when manifesting overt cognitive impairment, they had normal cortical rCBF and presumably cortical metabolism.
Because the "resting state" is poorly controlled in terms of patient behaviour and psychological experience and may be physiologically variable,51 52 interpretation of resting brain metabolism and rCBF data in the context of studying mental function is problematic. 51 We have attempted to reduce interindividual variance ("noise") in rCBF data by engaging patients in explicit behaviours during the procedure and by having each subject serve as his or her own control. In the present study, one of the behaviours was selected because it appears to be mediated by cortical neuronal systems implicated in Huntington's disease and because it is usually impaired in patients with this illness.7 19 This was the Wisconsin Card Sorting Test (WCS), a task that places a premium on dorsolateral prefrontal cortical function. It was hypothesised that by examining cortical rCBF during cognition specifically keyed to prefrontal cortex, the relationship of prefrontal physiology to prefrontal-type cognitive deficits in Huntington's disease could be more directly appreciated.
The other explicit behaviour was a simple number matching test that posed no difficulties for Hunt- ington's disease patients and that served as an rCBF baseline for comparison with rCBF during the WCS. We have previously found that by comparing rCBF during a regionally specific cognitive task with rCBF during an active baseline, many of the nonspecific physiological correlates of the primary task are eliminated, and rCBF that is specifically related to this task is highlighted.30 48 -50 Despite these efforts to isolate prefrontal physiology and to place prefrontal cortex under a selective functional "load", we could not demonstrate a reduction in prefrontal or other regional cortical activity in this Huntington's disease sample. rCBF did not differ between patients and controls during either of the explicit behavioural conditions. Furthermore, although patients did not tend to activate prefrontal cortex during the WCS over that during the NM quite as much as did the controls, this difference also was not statistically significant. These data suggest, therefore, that not withstanding the limitation of the xenon rCBF technique, prefrontal-type cognitive deficits in early Huntington's disease are the result of some mechanism other than a physiological abnormality intrinsic to prefrontal cortex.
Prefrontal-type cognitive deficits such as those typified by poor performance on the WCS are not illness specific, as they are associated with many disorders, including Alzheimer's disease,53 Parkinson's disease,53 54 progressive supranuclear palsy,53 55 multiple sclerosis,56 schizophrenia,30 as well as normal aging. 35 It is unlikely that the pathophysiological mechanisms underlying this behavioural abnormality are the same in these pathologically and aetiologically diverse conditions. The results of in vivo brain metabolism studies may help define the various mechanisms involved. For example, in Alzheimer's disease, frontal cortex glucose metabolism and rCBF are typically reduced both at rest57 -and during mental activation.60 This hypometabolic pattern is not surprising in light of findings in Alzheimer's disease of neuronal degeneration in prefrontal cortex. The results suggest that the mechanism of prefrontal-type cognitive deficits in this illness is direct impairment of intrinsic cortical processing systems.
There is also evidence from in vivo brain metabolism and rCBF studies of prefrontal metabolic abnormalities in patients with Parkinson's disease,6' -63 progressive supranuclear palsy,64 multiple sclerosis,65 and schizophrenia,3066 though this evidence is less consistent that in Alzheimer's disease. It has been proposed that a different mechanism, namely prefrontal deafferentation, accounts for the prefrontal hypometabolism seen in Parkinson's disease,37 38 in progressive supranuclear palsy,64 and in schizophrenia.30 In a study of Parkinson's disease using a paradigm identical to the present study, the results Weinberger, Berman, Iadarola, Driesen, Zec were clearly distinct from those of Huntington's disease; we found a strong positive correlation between prefrontal rCBF and performance on the WCS. 49 It is interesting to note that a similar finding emerged in a study of patients with schizophrenia.30 Whether this direct clinical-pathophysiological correlation suggests a deafferentiation mechanism for the prefrontal-type cognitive deficits seen in these disorders or not, it does suggest a different mechanism from the one implicated in this study of Huntington's disease.
Although we did not find a strong relationship between prefrontal rCBF and cognitive function in Huntington's disease, prefrontal rCBF (as well as blood flow in other cortical areas) did correlate with the degree of caudate atophy. There were two important features of this correlation. First of all, it was behaviourally specific, occurring only during the WCS condition. This novel finding suggests that the effect of caudate degeneration on cortical function is most pronounced during mental activity in which there is heightened demand for prefrontal function. Since most of the cortical input to the head of the caudate comes from prefrontal association cortex,67 68 it is, perhaps, not surprising that caudate pathology preferentially disrupts the "downstream" processing of information from this source. One clinical implication of this is that patients with early Huntington's disease, who tend to have degenerative neuropathological changes confined to the head of the caudate,45 may evince only minimal behavioural abnormalities unless specifically engaged in mental activities that place a premium on prefrontal function, such as exercising critical judgement, planning for the future, solving complex problems, etc. This may also explain why family members and employers are often the first to perceive subtle behavioural changes.
The second feature of the relationship between caudate pathology and rCBF is that they were directly correlated. The greater the caudate atrophy, the more cortical rCBF was found during the WCS and the more it increased over the NM baseline. While this correlation may at first seem paradoxical, it may also represent direct physiological evidence of the mechanism of the failure of prefrontal cognitive function in Huntington's disease. It is tempting to interpret this finding as indicative of the normal physiological response of a normal prefrontal cortex to downstream blockage at the head of the caudate, the primary first order corticofugal projection site. In other words, prefrontal cortex metabolism and presumably functional output increased in proportion to the degree of its "decoupling" with caudate, as if attempting to compensate for or to get through an outflow block. The tendency for poorer performance on the WCS to be associated with greater cortical Prefrontal cortical bloodflow and cognitive function in Huntington's disease activation can be viewed as consistent with this interpretation.
It should be noted that while the relationship between cortical rCBF and subcortical pathology was found only during the prefrontal behavioural condition, this relationship was not confined to rCBF only in frontal cortex. The correlations with temporal and parietal rCBF are more difficult to interpret in light of the limited projections of these regions to head of caudate and also considering that these areas are not directly implicated in performing the WCS. One possibility is that changes in metabolic activity in these non-frontal association areas during the WCS is secondary to changes in prefrontal activity, an interpretation consistent with the intracortical connectivities of prefrontal cortex and with data from PET and rCBF studies indicating that metabolic activity among cortical regions is highly intercorrelated. 69 Finally, while these results may be interpreted as evidence in support of the "subcortical dementia" concept, they also suggest a qualification of this concept. In the original descriptions of the "subcortical dementia" syndrome, it was conceded that the cognitive deficits were indistinguishable from those associated with frontal lobe disease.2'1 22 In the present study, the dementia involved a cognitive function thought to be mediated by neuronal systems intrinsic to prefrontal cortex. There is no compelling reason to believe that the dementia itself is subcortical simply because the primary pathology is located there. The data presented here suggest that the dementia represents a loss of neocortical (particularly prefrontal) function and that the role of subcortical pathology is in determining the pathophysiologic mechanism by which this function is lost.
We are especially grateful to Marjorie Gillespie, RN for invaluable assistance. We thank Susan Folstein, MD and Thomas Chase, MD for granting permission to study some of their patients. Sarah Rosenbaum and Catherine Brasher helped with graphics and Gail A Miller helped prepare the manuscript.
